New Orleans Pulmonary Hypertension Biobank
Louisiana State University Health Sciences Center in New Orleans · NCT03269630
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 450
- US sites recruiting
- 1
- Study start
- December 29, 2017
- Record last updated
- September 10, 2021
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Pulmonary hypertension (PH) is a serious condition characterized by a mean pulmonary artery pressure >=25mmHg on right heart catheterization (RHC). Despite advances in PH care, outcomes are still sub-optimal and further research is required into the pathobiology of the disease and development of biomarkers that can guide clinical care. The investigators are establishing a biobank to collect samples (blood, urine, stool) from patients with pulmonary hypertension, patients at high risk for pulmonary hypertension, healthy controls, and patients undergoing right heart catheterization. Specimens will be stored for future investigations.
Being studied: No intervention. Biospecimen collection only
Conditions: Pulmonary Hypertension; Systemic Sclerosis; Mixed Connective Tissue Disease; Heart Failure With Normal Ejection Fraction; Healthy
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Diagnosis of pulmonary hypertension and followed at the Comprehensive Pulmonary Hypertension Center OR
- Diagnosis of systemic sclerosis and followed at the Comprehensive Pulmonary Hypertension Center OR
- Diagnosis of mixed connective tissue disease and followed at the Comprehensive Pulmonary Hypertension Center OR
- Undergoing outpatient right heart catheterization
Exclusion Criteria
- Age\<18
- Pregnant
- Unable to understand English
- Currently incarcerated
- Unwilling or unable to sign informed consent
Recruiting US locations
University Medical Center-New Orleans
New Orleans, LA 70112
Site contact: Matthew Lammi, MD, MSCR · 504-568-4634 · mlammi@lsuhsc.edu
Study contacts (from the official record)
- Matthew R Lammi, MD, MSCR · 5045684634 · mlammi@lsuhsc.edu
Similar studies in Louisiana
All heart & blood pressure studies in Louisiana →- RecruitingPhase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
AstraZeneca
- Location
- Alexandria, LA + 151 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Regeneron Pharmaceuticals
- Location
- West Monroe, LA + 41 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Novo Nordisk A/S
- Location
- New Orleans, LA + 58 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated…
Pulnovo Medical, Inc.
- Location
- Houma, LA + 12 other US sites
- Eligibility basics
- Ages 18–85